Crossmark Global Holdings Inc. acquired a new stake in Perrigo Company (NYSE:PRGO) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 7,146 shares of the company’s stock, valued at approximately $605,000.

Several other large investors also recently added to or reduced their stakes in PRGO. Korea Investment CORP boosted its position in shares of Perrigo by 142.0% in the second quarter. Korea Investment CORP now owns 1,331 shares of the company’s stock valued at $101,000 after acquiring an additional 781 shares during the period. Commonwealth Bank of Australia boosted its position in shares of Perrigo by 13.8% in the second quarter. Commonwealth Bank of Australia now owns 1,455 shares of the company’s stock valued at $108,000 after acquiring an additional 176 shares during the period. Bessemer Group Inc. boosted its position in shares of Perrigo by 1,046.2% in the second quarter. Bessemer Group Inc. now owns 2,235 shares of the company’s stock valued at $169,000 after acquiring an additional 2,040 shares during the period. BlueCrest Capital Management Ltd bought a new stake in shares of Perrigo in the second quarter valued at about $221,000. Finally, NJ State Employees Deferred Compensation Plan bought a new stake in shares of Perrigo in the second quarter valued at about $227,000. Hedge funds and other institutional investors own 82.47% of the company’s stock.

Perrigo Company (NYSE PRGO) opened at $87.00 on Friday. The company has a market cap of $12,084.13, a PE ratio of 17.51, a PEG ratio of 1.85 and a beta of 0.69. The company has a quick ratio of 1.24, a current ratio of 1.72 and a debt-to-equity ratio of 0.54. Perrigo Company has a fifty-two week low of $63.68 and a fifty-two week high of $91.73.

Perrigo (NYSE:PRGO) last posted its earnings results on Thursday, November 9th. The company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.28. The firm had revenue of $1.22 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Perrigo had a negative net margin of 26.28% and a positive return on equity of 11.60%. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.65 earnings per share. equities research analysts forecast that Perrigo Company will post 4.88 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 19th. Stockholders of record on Friday, December 1st will be issued a $0.16 dividend. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.74%. Perrigo’s dividend payout ratio (DPR) is currently -6.99%.

PRGO has been the subject of a number of recent research reports. Cantor Fitzgerald set a $93.00 target price on shares of Perrigo and gave the company a “buy” rating in a research report on Thursday, August 10th. Canaccord Genuity reissued a “buy” rating and issued a $88.00 target price (up previously from $80.00) on shares of Perrigo in a research report on Thursday, August 10th. Deutsche Bank AG boosted their target price on shares of Perrigo from $88.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday, September 14th. Oppenheimer Holdings, Inc. initiated coverage on shares of Perrigo in a research report on Monday, October 2nd. They issued a “buy” rating and a $88.00 target price for the company. Finally, UBS AG reissued a “buy” rating and issued a $98.00 target price (up previously from $84.00) on shares of Perrigo in a research report on Thursday, October 5th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $91.50.

In other news, EVP Sharon Kochan sold 318 shares of the stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $81.36, for a total value of $25,872.48. Following the completion of the transaction, the executive vice president now owns 10,231 shares of the company’s stock, valued at $832,394.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Jeffrey Needham sold 3,595 shares of the stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $89.49, for a total transaction of $321,716.55. Following the completion of the transaction, the executive vice president now directly owns 10,118 shares of the company’s stock, valued at approximately $905,459.82. The disclosure for this sale can be found here. Insiders sold 6,029 shares of company stock valued at $513,504 in the last three months. Company insiders own 6.90% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This article was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/11/17/crossmark-global-holdings-inc-acquires-new-holdings-in-perrigo-company-prgo.html.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company (NYSE:PRGO).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Stock Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related stocks with our FREE daily email newsletter.